Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 510386, 8 pages
http://dx.doi.org/10.1155/2015/510386
Research Article

The Epidemiology and Economic Burden of Clostridium difficile Infection in Korea

1Department of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea
2Department of Medical Education and Medical Humanities, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea
3Cancer Policy Branch, National Cancer Control Institute, National Cancer Center, Goyang 410-769, Republic of Korea
4Department of Preventive Medicine, College of Medicine, Korea University, Seoul 136-701, Republic of Korea

Received 18 September 2014; Accepted 26 January 2015

Academic Editor: Hon W. Koon

Copyright © 2015 Hyung-Yun Choi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Pituch, “Clostridium difficile is no longer just a nosocomial infection or an infection of adults,” International Journal of Antimicrobial Agents, vol. 33, no. 1, pp. S42–S45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Kyne, M. B. Hamel, R. Polavaram, and C. P. Kelly, “Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile,” Clinical Infectious Diseases, vol. 34, no. 3, pp. 346–353, 2002. View at Google Scholar · View at Scopus
  3. L. Kyne, M. Warny, A. Qamar, and C. P. Kelly, “Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A,” The New England Journal of Medicine, vol. 342, no. 6, pp. 390–397, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. J. Lee, M. G. Choi, C. H. Lim et al., “Change of Clostridium difficile colitis during recent 10 years in Korea,” The Korean Journal of Gastroenterology, vol. 55, no. 3, pp. 169–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. S. Kim, D. S. Han, Y. H. Kim et al., “Incidence and clinical features of Clostridium difficile infection in Korea: a nationwide study,” Epidemiology and Infection, vol. 141, no. 1, pp. 189–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Ghantoji, K. Sail, D. R. Lairson, H. L. DuPont, and K. W. Garey, “Economic healthcare costs of Clostridium difficile infection: a systematic review,” Journal of Hospital Infection, vol. 74, no. 4, pp. 309–318, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Song, J. G. Bartlett, K. Speck, A. Naegeli, K. Carroll, and T. M. Perl, “Rising economic impact of Clostridium difficile-associated disease in adult hospitalized patient population,” Infection Control and Hospital Epidemiology, vol. 29, no. 9, pp. 823–828, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. E. N. Perencevich and K. A. Thom, “Preventing Clostridium difficile-associated disease: is it time to pay the piper?” Infection Control and Hospital Epidemiology, vol. 29, no. 9, pp. 829–831, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. E. R. Dubberke, D. N. Gerding, D. Classen et al., “Strategies to prevent Clostridium difficile infections in acute care hospitals,” Infection Control and Hospital Epidemiology, vol. 29, pp. S81–S92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. R. Dubberke and A. I. Wertheimer, “Review of current literature on the economic burden of Clostridium difficile infection,” Infection Control and Hospital Epidemiology, vol. 30, no. 1, pp. 57–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. C. P. Kelly, C. Pothoulakis, and J. T. LaMont, “Clostridium difficile colitis,” The New England Journal of Medicine, vol. 330, no. 4, pp. 257–262, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. G. E. Bignardi, “Risk factors for Clostridium difficile infection,” Journal of Hospital Infection, vol. 40, no. 1, pp. 1–15, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Barbut and J.-C. Petit, “Epidemiology of Clostridium difficile-associated infections,” Clinical Microbiology and Infection, vol. 7, no. 8, pp. 405–410, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. K. W. Garey, T. K. Dao-Tran, Z. D. Jiang, M. P. Price, L. O. Gentry, and H. L. DuPont, “A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics,” Journal of Hospital Infection, vol. 70, no. 2, pp. 142–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Freeman and M. H. Wilcox, “Antibiotics and Clostridium difficile,” Microbes and Infection, vol. 1, no. 5, pp. 377–384, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. J. G. Bartlett, “Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas,” European Journal of Gastroenterology & Hepatology, vol. 8, no. 11, pp. 1054–1061, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Ho, D. Yang, F. A. Wyle, and M. E. Mulligan, “Increased incidence of Clostridium difficile-associated diarrhea following decreased restriction of antibiotic use,” Clinical Infectious Diseases, vol. 23, no. 1, pp. S102–S106, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Warny, J. Pepin, A. Fang et al., “Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe,” The Lancet, vol. 366, no. 9491, pp. 1079–1084, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. E. J. Kuijper, B. Coignard, J. S. Brazier et al., “Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe,” Euro Surveillance, vol. 12, no. 6, pp. E1–E2, 2007. View at Google Scholar · View at Scopus
  20. L. C. McDonald, M. Owings, and D. B. Jernigan, “Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003,” Emerging Infectious Diseases, vol. 12, no. 3, pp. 409–415, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. S. H. Cohen, D. N. Gerding, S. Johnson et al., “Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA),” Infection Control and Hospital Epidemiology, vol. 31, no. 5, pp. 431–455, 2010. View at Publisher · View at Google Scholar
  22. H. Kim, T. V. Riley, M. Kim et al., “Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis,” Journal of Clinical Microbiology, vol. 46, no. 3, pp. 1116–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. Health Insurance Review & Assessment Service, http://www.hira.or.kr/.
  24. Y.-K. Lee, S. Jang, H. J. Lee, C. Park, Y.-C. Ha, and D.-Y. Kim, “Mortality after vertebral fracture in Korea,” Osteoporosis International, vol. 23, no. 7, pp. 1859–1865, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-H. Lee, S.-J. Yoon, E.-J. Kim, Y.-A. Kim, H.-Y. Seo, and I.-H. Oh, “Economic burden of asthma in Korea,” Allergy and Asthma Proceedings, vol. 32, no. 6, pp. e35–e40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-J. Lim, H.-J. Kim, C.-M. Nam et al., “Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database,” Journal of Preventive Medicine and Public Health, vol. 42, no. 4, pp. 251–260, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. Korean Statistical Information Service, http://www.kosis.kr.
  28. M. D. Redelings, F. Sorvillo, and L. Mascola, “Increase in Clostridium difficile-related mortality rates, United States, 1999–2004,” Emerging Infectious Diseases, vol. 13, no. 9, pp. 1417–1419, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Office for National Statistics, “Deaths involving Clostridium difficile, England and Wales,” 2012, http://www.ons.gov.uk/ons/search/index.html?newquery=Deaths+involving+Clostridium+difficile%2C+England+and+Wales%2C+2012.
  30. National Health Insurance Service, A Survey on Medical Charges (Korean), National Health Insurance Service, 2009.
  31. Korea Health Panel, http://www.khp.re.kr.
  32. J. Kim, H. Pai, M.-R. Seo, and J. O. Kang, “Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean tertiary hospital,” Journal of Korean Medical Science, vol. 26, no. 10, pp. 1258–1264, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. Korea Institute for Health and Social Affairs and The Ministry of Health and Welfare, An In-Depth Analysis on Consumption and Sales of Medicine in 2011, Korea Institute for Health and Social Affairs & The Ministry of Health and Welfare, 2011, (Korean).
  34. S. I. Kim, J. M. Park, S. H. Wie, Y. R. Kim, and M. W. Kang, “The trend of antibiotics usage in Korea during 1981–1998,” Korean Journal of Infectious Disease, vol. 32, no. 6, pp. 439–437, 2000. View at Google Scholar
  35. S. M. McGlone, R. R. Bailey, S. M. Zimmer et al., “The economic burden of Clostridium difficile,” Clinical Microbiology and Infection, vol. 18, no. 3, pp. 282–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Bryant and L. C. McDonald, “Clostridium difficile infections in children,” The Pediatric Infectious Disease Journal, vol. 28, no. 2, pp. 145–146, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Kim, M. Hahm II, E.-C. Park, J.-H. Park, S. E. Kim, and S. G. Kim, “Economic burden of cancer in South Korea for the year 2005,” Journal of Preventive Medicine and Public Health, vol. 42, no. 3, pp. 190–198, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. H.-J. Kim, Y.-A. Kim, H.-Y. Seo, E.-J. Kim, S.-J. Yoon, and I.-H. Oh, “The economic burden of stroke in 2010 in Korea,” Journal of the Korean Medical Association, vol. 55, no. 12, pp. 1226–1236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Kim, M.-R. Seo, J. O. Kang, T. Y. Choi, and H. Pai, “Clinical and microbiologic characteristics of Clostridium difficile infection caused by binary toxin producing strain in Korea,” Infection & Chemotherapy, vol. 45, no. 2, pp. 175–183, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J. S. Sammons, R. Localio, R. Xiao, S. E. Coffin, and T. Zaoutis, “Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children,” Clinical Infectious Diseases, vol. 57, no. 1, pp. 1–8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. B. J. Park, J. H. Sung, K. D. Park et al., “Strategies to improve the validity of diagnostic codes of National Health Insurance claims data,” Tech. Rep., Health Insurance Review and Assessment Services, Seoul, Republic of Korea, 2012. View at Google Scholar